Metabolism of heme and novel drug design
Akagi, R.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 130(4): 247
2007
ISSN/ISBN: 0015-5691 PMID: 18064782 Document Number: 609320
Document emailed within 1 workday
Related Documents
Furuyama, K.; Sassa, S. 2003: Heme biosynthesis and iron metabolism Seikagaku. Journal of Japanese Biochemical Society 75(3): 179-186Kaliman, P.A.; Barannik, T.B. 2001: Heme metabolism and oxidative stress Ukrains'kyi Biokhimichnyi Zhurnal 73(1): 5-15
Akagi, R. 2007: Diversity of physiological functions mediated by heme metabolism Seikagaku. Journal of Japanese Biochemical Society 79(5): 441-445
Farrell, G.C.; Cooksley, W.G.; Hart, P.; Powell, L.W. 1978: Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism Gastroenterology 75(4): 580-588
Sharma, G.D.; Kamboj, K.K. 1995: Studies on heme and heme oxygenase during Plasmodium berghei infection in golden hamsters Indian Journal of Experimental Biology 33(11): 897-898
Kaliman, P.A.; Nikitchenko, I.V. 1989: Activity of key enzymes of heme metabolism and the content of several hemoproteins in the liver of rats of various ages Ukrainskii Biokhimicheskii Zhurnal 61(1): 75-78
Docherty, J.C.; Masters, B.S.; Firneisz, G.D.; Schacter, B.A. 1982: Heme oxygenase provides alpha-selectivity to physiological heme degradation Biochemical and Biophysical Research Communications 105(3): 1005-1013
Gondal, J.A.; Eiseman, J.L.; Alvares, A.P. 1987: Regulation of heme metabolism and monooxygeneses in liver and kidney: influence of therapeutically used gold compounds Journal of Pharmacology and Experimental Therapeutics 241(2): 540-546
Naughton, P.; Hoque, M.; Green, C.J.; Foresti, R.; Motterlini, R. 2002: Interaction of heme with nitroxyl or nitric oxide amplifies heme oxygenase-1 induction: involvement of the transcription factor Nrf2 Cellular and Molecular Biology 48(8): 885-894
Bonkovsky, H.L.; Healey, J.F.; Lourie, A.N.; Gerron, G.G. 1991: Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools American Journal of Gastroenterology 86(8): 1050-1056
Jenke, D. 2010: Application of Quality by Design (QbD) Principles to Extractables/Leachables Assessment. Establishing a Design Space for Terminally Sterilized Aqueous Drug Products Stored in a Plastic Packaging System PDA Journal of Pharmaceutical Science and Technology 64(6): 527-535
Matsuura, Y.; Fukuda, T.; Yoshida, T.; Kuroiwa, Y. 1984: Induction of hepatic heme oxygenase and its effect on drug metabolizing enzyme by DL-, D- and L-ethionine administration to rats Research Communications in Chemical Pathology and Pharmacology 45(1): 81-96
Ayala, R.C.; Arya, V.; Younis, I.R. 2016: Design Features of Drug-Drug Interaction Trials Between Antivirals and Oral Contraceptives Journal of Clinical Pharmacology 56(5): 541-547
Guo, Z.-r. 2008: Strategy of molecular drug design: hits, leads and drug candidates Yao Xue Xue Bao 43(9): 898-904
Kutter, E.; Austel, V. 1981: Application of the theory of sets to drug design. Development of a new cardiotonic drug AR-L 115 BS Arzneimittel-Forschung 31(1a): 135-141
Kashyap, A.; Singh, P.Kumar.; Silakari, O. 2018: Counting on Fragment Based Drug Design Approach for Drug Discovery Current Topics in Medicinal Chemistry 18(27): 2284-2293
Luna, D.; Otero, C.; Risk, M.; Stanziola, E.; González Bernaldo de Quirós, Fán. 2016: Impact of Participatory Design for Drug-Drug Interaction Alerts. A Comparison Study Between Two Interfaces Studies in Health Technology and Informatics 228: 68-72
Maines, M.D.; Mayer, R.D.; Ewing, J.F.; McCoubrey, W.K. 1993: Induction of kidney heme oxygenase-1 (HSP32) mRNA and protein by ischemia/reperfusion: possible role of heme as both promotor of tissue damage and regulator of HSP32 Journal of Pharmacology and Experimental Therapeutics 264(1): 457-462
Luna, D.R.; Rizzato Lede, D.A.; Rubin, L.; Otero, C.M.; Ortiz, J.M.; García, Mónica.G.; Rapisarda, R.P.; Risk, M.R.; González Bernaldo de Quirós, Fán. 2017: User-Centered Design Improves the Usability of Drug-Drug Interaction Alerts: A Validation Study in the Real Scenario Studies in Health Technology and Informatics 245: 1085-1089
Smith, D.A.; Jones, B. 1999: Variability in drug response as a factor in drug design Current Opinion in Drug Discovery and Development 2(1): 33-41